JCI & NABH-accredited transplant units Free specialist opinion within 48 hours Patients from 20+ countries
Patient guide · Sickle cell

Sickle Cell Disease Cure in India: Bone Marrow Transplant Guide for Nigerian Families

Hydroxyurea and transfusions manage sickle cell disease. A bone marrow transplant can end it. Here's how it works, who it suits, and what the results look like.

Illustration of sickle-shaped red blood cells changing into healthy round red blood cells after a bone marrow transplant

Hydroxyurea, folic acid, transfusions, painkillers at 2 a.m. Many Nigerian families know that routine by heart. Those treatments help a great deal, but they manage the disease. They don't remove it.

A bone marrow transplant is different. It replaces the marrow that makes sickle-shaped cells with healthy marrow from a donor. When it works, your child no longer has sickle cell disease.

How a transplant cures sickle cell

How a bone marrow transplant cures sickle cell diseaseChild's marrowmakes sickle cellsConditioningchemo clears the marrowDonor stem cellsgiven through a dripNew marrowhealthy red cells in 2–4 wks
The four stages of a bone marrow transplant for sickle cell disease.

The faulty haemoglobin is made in the bone marrow. Chemotherapy first clears your child's own marrow. Stem cells from a healthy donor are then given through a drip. They travel to the bones, settle in, and start making normal red cells within a few weeks. A brother or sister with sickle cell trait (AS) can usually still donate.

Which children are good candidates

Results are best in children, ideally before the disease has damaged the brain, lungs or kidneys. Doctors usually recommend a transplant after a stroke or an abnormal transcranial Doppler scan, repeated acute chest syndrome, frequent crises despite hydroxyurea, or regular transfusions. The treating transplant specialist makes the final call.

What the results look like

A fully matched sibling gives the best odds. In an international study of 1,000 such transplants, 92.9% of patients were alive five years later and 91.4% were alive and free of sickle cell disease. Younger patients did better.

Five-year results of 1,000 matched sibling transplants for sickle cell disease92.9%Alive at 5 yearsoverall survival91.4%Alive and sickle-cell freeevent-free survival
Five-year results of 1,000 matched sibling transplants for sickle cell disease (Gluckman et al., Blood, 2017).

Half-matched transplants from a parent have improved a lot in the past decade, though they carry more risk. That's why we ask families to test every full sibling first.

Donor options for a sickle cell transplant in India
DonorWhoWhat to expectCost in India
Matched siblingFull brother or sister, 10/10 matchBest results; around 9 in 10 cured in large studiesfrom $25,000
Half-matched (haplo)Parent or half-matched siblingGood and improving; more risk of rejection and GVHDfrom $35,000
Matched unrelatedRegistry volunteerPossible, but donors of African ancestry are scarce on registrieson request

The risks, stated plainly

A transplant is a serious undertaking. The main risks are infection while immunity is low, graft-versus-host disease (donor cells attacking the body), graft failure, and reduced fertility from chemotherapy. Fertility preservation can be discussed beforehand. A good team talks through all of this openly, and you should expect them to.

Why Nigerian families choose India

India has a large sickle cell population of its own, so its transplant haematologists treat this disease often. Matched sibling transplants start from USD 25,000 and most families stay about three months. Compare the hospitals and doctors, the full cost picture and how the process works, or read our India vs Nigeria cost comparison and step-by-step guide.

Where to start

Send us your child's electrophoresis report, recent blood counts and a short medical history. A senior transplant specialist reviews it within 48 hours, at no cost to you.

BMT Treatment India helps families from Nigeria and across Africa plan bone marrow transplants at accredited hospitals in India, from the first report to the flight home.

Sources and notes. Survival figures: Gluckman E, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood, 2017. This article is general information, not medical advice; only the treating transplant physician can confirm whether a transplant is suitable for your child.

Get a specialist opinion for your child

Send the electrophoresis report and recent blood counts. A senior transplant specialist replies within 48 hours, at no charge.

Medical disclaimer. BMT Treatment India is a patient-facilitation service, not a hospital or healthcare provider. The information on this page is general education and is not a substitute for professional medical advice, diagnosis or treatment. Costs, durations and outcomes are indicative and vary by diagnosis, donor availability, centre and clinical condition; only a treating transplant physician can confirm suitability, and only the hospital can issue a binding estimate. Always seek the advice of a qualified doctor regarding your medical condition.
WhatsApp us